In the Phase 2 trial, 72% of participants who had prediabetes at the start had normal glycated hemoglobin levels at 48 weeks, compared to just 22% on placebo
Liraglutide and tirzepatide are effective for weight loss but have a poorer safety profile and higher discontinuation rates due to adverse events
Dosage for Weight Loss The dosage of weight loss drugs differs from those used in the treatment of type 2 diabetes or prediabetes
Gallbladder-related risks are heightened during rapid weight loss, as demonstrated in trials of GLP-1 therapies and in dietary interventions such as very-low-calorie diets [33,36]
Clinical trial data for women: A 2025 analysis of the SURMOUNT trials specifically looked at whether reproductive stage (premenopausal, perimenopausal, postmenopausal) affected weight loss with tirzepatide
They only contain herbal blends or vitamins with zero clinical evidence that they help with weight loss or metabolic health